B-Y Lee Selected Research

N-dehydroxyethylmirodenafil

2/2010

Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B-Y Lee Research Topics

Disease

1	Nausea 04/2015
1	Vomiting 04/2015
1	Urinary Incontinence 08/2013
1	Diabetes Mellitus 02/2010
1	Classical Swine Fever (Swine Fever) 01/2008

Drug/Important Bio-Agent (IBA)

1	Ondansetron (Zofran)FDA LinkGeneric 04/2015
1	AntiemeticsIBA 04/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2013
1	Serotonin (5 Hydroxytryptamine)IBA 08/2013
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 08/2013
1	mirodenafilIBA 02/2010
1	N-dehydroxyethylmirodenafilIBA 02/2010
1	2- (4- (3- (5- ethyl- 7- n- propyl- 3,5- dihydro- 4H- pyrrolo(3,2- d)pyrimidin- 4- onyl)- 4- n- propoxyphenyl)sulfonylpiperazin- 1- yl)ethyl hydrogen sulfateIBA 02/2010
1	Streptozocin (Streptozotocin)FDA Link 02/2010
1	AntibodiesIBA 01/2008
1	VaccinesIBA 01/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 04/2015
1	Oral Administration 02/2010
1	Intravenous Administration 02/2010